These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Flowcytometric detection of PNH defect in Indian patients with aplastic anemia and myelodysplastic syndromes. Varma N; Garewal G; Varma S; Vohra H Am J Hematol; 2000 Nov; 65(3):264-5. PubMed ID: 11074548 [No Abstract] [Full Text] [Related]
8. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome. Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157 [TBL] [Abstract][Full Text] [Related]
9. Clonal evolution in aplastic anemia. Afable MG; Tiu RV; Maciejewski JP Hematology Am Soc Hematol Educ Program; 2011; 2011():90-5. PubMed ID: 22160018 [TBL] [Abstract][Full Text] [Related]
10. Clinical spectrum and clonal evolution in germline syndromes with predisposition to myeloid neoplasms. Perez Botero J; Ho TP; Hogan WJ; Kenderian S; Gangat N; Tefferi A; Abraham RS; Nguyen P; Oliveira JL; He R; Chen D; Viswanatha D; Rodriguez V; Khan SP; Patnaik MM Br J Haematol; 2018 Jul; 182(1):141-145. PubMed ID: 28485484 [No Abstract] [Full Text] [Related]
12. The evolution of paroxysmal nocturnal haemoglobinuria depends on intensity of immunosuppressive therapy. Bat T; Abdelhamid ON; Balasubramanian SK; Mai A; Radivoyevitch T; Clemente M; Maciejewski JP Br J Haematol; 2018 Sep; 182(5):730-733. PubMed ID: 28804905 [No Abstract] [Full Text] [Related]
13. [The dynamics of paroxysmal nocturnal hemoglobinuria clone in patients with aplastic anemia in process of immune suppressive therapy]. Fidarova ZT; Mikhailova EA; Galtseva IV; Lugovskaya SA; Naumova EV; Troitskaya VV; Ustinova EN; Davydova YO; Kapranov NM; Abramova AV; Parovichnikova EN; Savchenko VG Klin Lab Diagn; 2016 Aug; 61(8):490-4. PubMed ID: 30601641 [TBL] [Abstract][Full Text] [Related]
14. COVID-19 in patients with paroxysmal nocturnal haemoglobinuria: an Italian multicentre survey. Barcellini W; Fattizzo B; Giannotta JA; Quattrocchi L; Aydin S; Barone F; Carbone C; Pomponi F; Metafuni E; Beggiato E; Sica S; Di Bona E; Lanza F; Notaro R; Iori AP Br J Haematol; 2021 Sep; 194(5):854-856. PubMed ID: 34036575 [No Abstract] [Full Text] [Related]
15. Fatigue, symptom burden, and health-related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria. Escalante CP; Chisolm S; Song J; Richardson M; Salkeld E; Aoki E; Garcia-Manero G Cancer Med; 2019 Feb; 8(2):543-553. PubMed ID: 30632713 [TBL] [Abstract][Full Text] [Related]
16. Transient JAK2 V617F mutation in an aplastic anaemia patient with a paroxysmal nocturnal haemoglobinuria clone. Langabeer SE; Haslam K; O'Brien D; Enright H; Leahy M Br J Haematol; 2013 Apr; 161(2):297-8. PubMed ID: 23360357 [No Abstract] [Full Text] [Related]
17. Severe aplastic anemia associated with paroxysmal nocturnal hemoglobinuria and lymphoplasmacytic lymphoma. Veidt RG; Ansari-Lari A; Brodsky RA Leuk Lymphoma; 2005 Aug; 46(8):1243-6. PubMed ID: 16085570 [TBL] [Abstract][Full Text] [Related]
18. [Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria (PNH), with special reference to aplastic anemia-PNH syndrome]. Takahashi R Nihon Rinsho; 1978 Jul; 36(7):2740-5. PubMed ID: 702866 [No Abstract] [Full Text] [Related]